Clinical Trials
6
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis
- Conditions
- Chronic Bronchitis
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Gala Therapeutics, Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT04677465
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Norton Thoracic, Phoenix, Arizona, United States
🇺🇸Honor Health, Scottsdale, Arizona, United States
RheOx Registry Study in Europe
- Conditions
- Chronic BronchitisCOPD
- First Posted Date
- 2019-12-02
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Gala Therapeutics, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT04182841
- Locations
- 🇦🇹
Otto Wagner Spital, Wien, Austria
🇩🇪Pneumologie Thoraxklinik Heidelberg gGmbH University of Heidelberg, Heidelberg, Baden-Württemberg, Germany
Gala Early Feasibility Study of RheOx
- Conditions
- Chronic BronchitisCopd Bronchitis
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- Gala Therapeutics, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT03631472
- Locations
- 🇺🇸
University of Alabama Lung Health Center, Birmingham, Alabama, United States
🇺🇸Mayo Clinic Florida, Jacksonville, Florida, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
Gala Treatment for Chronic Bronchitis in Canada
- Conditions
- Chronic BronchitisCOPD
- First Posted Date
- 2017-12-28
- Last Posted Date
- 2021-08-04
- Lead Sponsor
- Gala Therapeutics, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03385616
- Locations
- 🇨🇦
St. Paul's Hospital Vancouver Centre for Heart Lung Innovation, Vancouver, British Columbia, Canada
🇨🇦Notre Dame Hospital at CHUM, Montreal, Canada
🇨🇦IUCPQ Quebec, Quebec, Canada
Gala FIH Feasibility Study for the Treatment of Chronic Bronchitis
- Conditions
- Chronic Bronchitis
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2020-09-01
- Lead Sponsor
- Gala Therapeutics, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT03107494
- Locations
- 🇦🇹
Otto Wagner Spital, Wien, Austria
🇨🇱Clinica Alemana, Santiago, Chile